Thai Interest Group for Endometriosis (TIGE) consensus statement on endometriosis-associated pain
Issued Date
2022-01-01
Resource Type
ISSN
01443615
eISSN
13646893
Scopus ID
2-s2.0-85126179792
Pubmed ID
35254183
Journal Title
Journal of Obstetrics and Gynaecology
Volume
42
Issue
6
Start Page
1607
End Page
1612
Rights Holder(s)
SCOPUS
Bibliographic Citation
Journal of Obstetrics and Gynaecology Vol.42 No.6 (2022) , 1607-1612
Suggested Citation
Wisawasukmongchol W. Thai Interest Group for Endometriosis (TIGE) consensus statement on endometriosis-associated pain. Journal of Obstetrics and Gynaecology Vol.42 No.6 (2022) , 1607-1612. 1612. doi:10.1080/01443615.2022.2036965 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/86648
Title
Thai Interest Group for Endometriosis (TIGE) consensus statement on endometriosis-associated pain
Author(s)
Other Contributor(s)
Abstract
This consensus statement has been developed by the Thai Interest Group for Endometriosis (TIGE) for use by Thai clinicians in the diagnosis and management of endometriosis. TIGE is a group of clinical and academic gynaecologists with a particular interest in endometriosis. Endometriosis is an oestrogen-dependent inflammatory disease which causes chronic symptoms such as dysmenorrhoea, chronic pelvic pain, dyspareunia and subfertility, and it is common in reproductive-age women. There is limited overall data on its prevalence in different clinical settings in Thailand, but it is clear that the disease causes significant problems for patients in terms of their working lives, fertility, and quality of life, as well as placing a great burden on national healthcare resources. Decisions about selecting the appropriate treatment for women with endometriosis depend on many factors including the age of the patient, the extent and severity of disease, concomitant conditions, economic status, patient preference, access to medication, and fertility need. Several hormonal treatments are available but no consensus has been reached about the best option for long-term prevention of recurrence. Bearing in mind differences in environment, genetics, and access to the healthcare system, this treatment guideline has been tailored to the particular circumstances of Thai women.